Megan McGill, MD, PhD
CEO, Board Member
Megan has over 10 years of experience across healthcare including clinical medicine,
research, management consulting, and drug development. She received a BA, magna cum laude,
from the University of Pennsylvania in neuroscience, chemistry and music. She completed her
MD and PhD degrees at New York University with a PhD in neuroimaging and MRI physics and was
elected to Alpha Omega Alpha Honor Medical Society. Megan trained as a radiologist at NYU
Langone Medical Center and previously held roles at McKinsey & Co. in the firm's healthcare
practice, Regenxbio, a gene therapy company, and BridgeBio, a genetic disease company. Megan
is currently the CEO of Epitor Therapeutics (epigenetic editing) and HitchBio (red blood
cell drug delivery).